zidovudine has been researched along with amphotericin b in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.11) | 18.7374 |
1990's | 10 (37.04) | 18.2507 |
2000's | 7 (25.93) | 29.6817 |
2010's | 7 (25.93) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charman, WN; Hamann, MT; Hammond, NL; Mayer, AM; McIntosh, KA; Peng, J; Wahyuono, S; Yousaf, M | 1 |
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Fan, X; Loiseau, PM; Torrence, PF; Zhang, X | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hansen, JE; Mathiesen, LR; Nielsen, C; Svenningsen, A; Witzke, N | 1 |
Glück, T; Weber, P; Wiedmann, KH | 1 |
Gil, A; Lavilla, P; López Dupla, JM; Pintado, V; Valencia, ME | 1 |
Borleffs, JC; Hoepelman, IM; Joore, JC; Marcelis, JH; Sie-Go, DM | 1 |
Mitchell, WM; Montefiori, DC; Robinson, WE | 1 |
Becker, P; Criner, GJ; Furth, P; Murray, RJ | 1 |
Rada, B | 1 |
Blay, RA; Buck, SM; Epstein, JS; Geyer, S; Mayner, RE; Pollock, L; Selvam, MP | 1 |
Adrados, M; Laguna, F; Martínez-Suárez, JV | 1 |
Lancaster, DJ; Palte, S; Ray, D | 1 |
Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
Adrados, M; Alvar, J; González-Lahoz, JM; Jiménez, MI; Laguna, F; Martínez, ML; Martínez, P; Moreno, V; Polo, R; Soriano, V; Valencia, ME; Verdejo, J | 1 |
Cuadrado, JM; Jover, F; Martínez-Baltanás, A; Roig, P | 1 |
Nicklas, JA; Walker, DM; Walker, VE | 1 |
Patrick O'Neill, J; Tyson, FL; Walker, DM; Walker, VE | 1 |
3 review(s) available for zidovudine and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug surveillance for adverse reactions in patients with human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Pentamidine; Product Surveillance, Postmarketing; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1990 |
[Experimental chemotherapy of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1988 |
1 trial(s) available for zidovudine and amphotericin b
Article | Year |
---|---|
Recombinant human erythropoietin in the treatment of anemia in AIDS patients receiving concomitant amphotericin B and zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anemia; Erythropoietin; Histoplasmosis; Humans; Recombinant Proteins; Zidovudine | 1993 |
23 other study(ies) available for zidovudine and amphotericin b
Article | Year |
---|---|
New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antifungal Agents; Biological Availability; Carbazoles; Carbolines; Fourier Analysis; HIV-1; Indoles; Injections, Intravenous; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Porifera; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro.
Topics: Animals; Antiprotozoal Agents; Inhibitory Concentration 50; Leishmania donovani; Pyrimidine Nucleosides; Structure-Activity Relationship | 2006 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synergistic antiviral effect in vitro of azidothymidine and amphotericin B methyl ester in combination on HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; HIV; HIV Infections; Humans; Zidovudine | 1992 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Male; Meningitis, Cryptococcal; Opportunistic Infections; Recurrence; Time Factors; Zidovudine | 1991 |
[Histoplasma capsulatum infection, a manifestation of AIDS unusual for The Netherlands].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Drug Therapy, Combination; Histoplasma; Histoplasmosis; Humans; Male; Zidovudine | 1990 |
In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Alkaloids; Amphotericin B; Antiviral Agents; Drug Therapy, Combination; Foscarnet; HIV; Humans; In Vitro Techniques; Indolizines; Interferon beta-1a; Interferon beta-1b; Interferon Type I; Interferon-beta; Interferon-gamma; Interferons; Microbial Sensitivity Tests; Phosphonoacetic Acid; Recombinant Proteins; Ribavirin; RNA, Double-Stranded; Zidovudine | 1989 |
Recovery from cryptococcemia and the adult respiratory distress syndrome in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antiviral Agents; Cryptococcosis; Humans; Intubation, Intratracheal; Male; Radiography; Respiratory Distress Syndrome; Thymidine; Zidovudine | 1988 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
Topics: Amphotericin B; Antiviral Agents; Cell Line, Transformed; Cell Survival; Foscarnet; HIV Core Protein p24; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Nystatin; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
[Fungemia caused by Candida krusei in a female patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida; Candidiasis, Oral; Female; Fluconazole; Fungemia; Humans; Recurrence; Zidovudine | 1994 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Allopurinol; Amebicides; Amphotericin B; Analysis of Variance; Anti-HIV Agents; Antimetabolites; Antimony; Antiprotozoal Agents; Blood; Bone Marrow; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Didanosine; Digestive System; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatic Encephalopathy; HIV; Humans; Intestinal Mucosa; Leishmaniasis, Visceral; Lymphocyte Count; Male; Myocarditis; Neutrophils; Pancreatitis; Pentamidine; Renal Insufficiency; Spain; Zidovudine | 1997 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Memory; Lamivudine; Lopinavir; Male; Meningitis, Cryptococcal; Pyrimidinones; Recurrence; Ritonavir; Syndrome; T-Lymphocyte Subsets; Zidovudine | 2005 |
The stress response resolution assay. II. Quantitative assessment of environmental agent/condition effects on cellular stress resolution outcomes in epithelium.
Topics: Amphotericin B; Animals; Cell Cycle Checkpoints; Cell Death; Cell Line; Cell Proliferation; Cell Shape; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Ethylnitrosourea; Guanine Nucleotides; Humans; Hypoxanthine Phosphoribosyltransferase; Lamivudine; Mice; Mutagens; Mutation; Phenotype; Stress, Physiological; Thionucleotides; Toxicity Tests; Zidovudine | 2013 |
The stress response resolution assay. I. Quantitative assessment of environmental agent/condition effects on cellular stress resolution outcomes in epithelium.
Topics: Amphotericin B; Animals; Calibration; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Environmental Exposure; Environmental Pollutants; Epithelial Cells; Epithelium; Ethylnitrosourea; Guanine Nucleotides; Humans; Lamivudine; Mice; Mutagens; Stress, Physiological; Thionucleotides; Toxicity Tests; Zidovudine | 2013 |